Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients

Documenti analoghi

• Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
  di: Yuki Konno, et al.
  Pubblicazione: (2025)
• Prognostic value of noninvasive programmed stimulation in primary prevention implantable cardioverter‐defibrillator recipients
  di: Piotr Futyma, et al.
  Pubblicazione: (2024)
• How to indicate implantable cardioverter‐defibrillator in the aging population
  di: Risako Orita, et al.
  Pubblicazione: (2025)
• Management of patients following implantable cardioverter‐defibrillator therapy—The importance of a multifaceted approach
  di: Karshana Selvarajah, et al.
  Pubblicazione: (2024)
• Prophylactic implantation of cardioverter‐defibrillator in patients with advanced light‐chain amyloidosis—A pilot study
  di: Hui‐Qiang Wei, et al.
  Pubblicazione: (2025)